,107,108 Our team has also determined that GPER promotes tamoxifen-resistance in ER+ BC cells by reducing B-cell lymphoma 2-like 11 (BCL2L11) proteins162 and mediates secondary drug resistance by regulating ABCG2 expression and membrane localization in tamoxifen-resistant BC.74 This evidence concerns the gene BCL2L11 and breast cancer.